GBA Presents: RADIO SAVANT-!

vanzandt said:
THE WOODLANDS, Texas, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the following investor conferences taking place November 29 - December 1, 2022:

34th Annual Piper Sandler Healthcare Conference
5th Annual Evercore ISI HealthCONx Conference

Lonnel Coats, Lexicon’s chief executive officer, Jeffrey L. Wade, Lexicon’s president and chief financial officer, and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer, will participate in moderated discussions at the Piper Sandler conference on Tuesday, November 29th, at 11:00 am ET and at the Evercore ISI conference on Thursday, December 1st at 8:00 am ET.

A simultaneous webcast of both discussions will be available in the “Events” section of the Lexicon website at www.lexpharma.com/events, and a recording of the webcast will be available for two weeks following the original on-demand date.

About Lexicon Pharmaceuticals

Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through its Genome5000™ program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon advanced one of these medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, diabetes and metabolism and other indications. For additional information, please visit www.lexpharma.com.
More...





This is all out you should look it up.

Lexicon Pharmaceuticals announced that the final results from the Phase 2 RELIEF-DPN-1 trial of its investigational drug LX9211, a novel, highly selective inhibitor of adaptor-associated kinase 1, will be presented during a podium presentation at the 16th Annual Pain Therapeutics Summit in Washington, D.C. The presentation will be given by Anand Patel, M.D., the Chief Medical Officer at Conquest Research and a principal investigator in the RELIEF-DPN-1 study, on November 14th at 3:35pm ET, and is entitled: "A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of LX9211 in the Treatment of Diabetic Peripheral Neuropathic Pain."
 
I like the heart failure drug!

Neuropathic pain is obviously a HUGE market and my step father had it bad, deff room for more than one player-- that's a nice oar to have in the water but for Big $'s move into next Spring LXRX seems like a smart play.

The trouble will be holding it.
 
This headline caught my eye-

Maine Beer Company installs Chart Industries' Earthy Labs CO2 capture technology

yet another green blah blah blah stock I looked it up.

Chart trades for $135.//

There is going to be a green wave in stocks.

But it's going to be in players like this-- You would never think.
 
Brings us back to water plays doesn't it? Genetic farming, vertical farming, Solar power,
elec cars, how do we get the earth's temp down?

So much to think about.

Booster shots?
 
vanzandt said:
If it goes up much from here, it'll be because the short interest is climbing daily.
I don't think Apple's Board would approve this, if it was in fact true.

They'd be better off buying Formula-E and flipping it to Disney.

I called it out at $15. I didn't buy any though.
If I were you, I'd take some off the table unless you feel confident there will in fact be a short squeeze.

That said, the figure I used as to what someone would be willing to pay for the franchise was from 2020. Hell that # might be 30% higher, which would value the shares around $30
More...




It's a tough call. It's up to you we could replace it with the bio!
 
Ok I had a bad run with The Drive Shack and my Best Gift of last Season non of you bought -the self powered no need for a friend golf bag that spits balls at you...

BUT WAIT-!

Kandi Technologies produces 10,000th crossover electric golf cart 09:08 KNDI

Ok maybe Avery says maybe to many times buy who cares...

SPECIAL GUEST-! THESE CARTS ARE SICK!

 
I love the Caribbean and on some islands especially Harbour this is how you get around!

You don't need a car and this is cooler than an EV you can wear flip flops and Santa Monica yes! This works for me.

 
Ooooooo wait. CEO name sounds Chinese.

Kandi Technologies reports Q3 EPS 1c vs (10c) last year 11/08 KNDI Reports Q3 revenue $33.7M vs $16.8M last year. Hu Xiaoming, Chairman and CEO of Kandi commented, "During the third quarter, our strategic pivot enabled us to make inroads in electric off-road vehicles. With high market interest in the electrification of off-road vehicles, we successfully developed and delivered "crossover" electric golf carts that are seeing high acceptance by our customers. Growing demand, and positive market feedback gives us more confidence to invest more in electric off-road vehicles. Our next step is to launch more models in the categories of golf crossovers, utility terrain vehicles, and more. We believe that our top line growth and disciplined control of operating expenses can drive improved profitability, which will be increasingly recognized by investors."

Hummmmm>

These poor poeple need these carts now to breakout of their Covid restrictions!!!!!
 
You must log in or register to reply here.
Back
Top